What to Know About Leqembi, the Alzheimer ’s Drug Approved by the FDA

Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science Alzheimer ' s Disease Health Insurance and Managed Care Medicare Content Type: Service Drugs (Pharmaceuticals) Brain Food and Drug Administration Source Type: news